Commodore Capital LP Celldex Therapeutics, Inc. Transaction History

Commodore Capital LP

$1.18 Billion
Q3 2024

A detailed history of Commodore Capital LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 1,618,937 shares of CLDX stock, worth $40.7 Million. This represents 4.67% of its overall portfolio holdings.

Number of Shares

1,618,937

Previous 1,425,000 13.61%

Holding current value

$40.7 Million

Previous $52.7 Million 4.28%

% of portfolio

4.67%

Previous 4.73%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $6.22 Million - $8.64 Million	193,937 Added 13.61%	1,618,937 $55 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $18.3 Million - $23.8 Million	558,532 Added 64.46%	1,425,000 $52.7 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $5.79 Million - $8.53 Million	164,501 Added 23.43%	866,468 $36.4 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $106,221 - $190,973	-4,698 Reduced 0.66%	701,967 $27.8 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $1.91 Million - $2.81 Million	75,000 Added 11.87%	706,665 $19.4 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $4.11 Million - $5.2 Million	135,842 Added 27.4%	631,665 $21.4 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $1.19 Million - $1.95 Million	-42,989 Reduced 7.98%	495,823 $22.1 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $6.1 Million - $11.1 Million	297,613 Added 123.39%	538,812 $14.5 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $6.67 Million - $9.48 Million	241,199 New	241,199 $8.22 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $8.86 Million - $14 Million	-248,207 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $2.18 Million - $4.21 Million	-75,230 Reduced 23.26%	248,207 $13.4 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $963,304 - $1.65 Million	-46,514 Reduced 12.57%	323,437 $10.8 Million
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $218,888 - $404,383	13,520 Added 3.79%	369,951 $7.62 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $5.34 Million - $8.11 Million	356,431 New	356,431 $6.25 Million

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.17B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Account

Commodore Capital LP Celldex Therapeutics, Inc. Transaction History